筛选条件 共查询到89条结果
排序方式
Potential biomarkers for inherited thrombocytopenia 2 identified by plasma proteomics

期刊: PLATELETS, 2022; 33 (3)

Inherited thrombocytopenia 2 (THC2) is difficult to diagnose due to the lack of specific clinical characteristics and diagnostic methods. To identify ......

JIF:2.779

Differential expression of exosomal microRNAs in fresh and senescent apheresis platelet concentrates

期刊: PLATELETS, 2022; 33 (8)

Plain Language Summary What is the context? Platelet transfusion is a widely used clinical treatment, but it is not totally safe. Side effects may hap......

JIF:2.779

Effect of iron supplementation on platelet count in adult patients with iron deficiency anemia

期刊: PLATELETS, 2022; 33 (8)

Iron deficiency anemia (IDA) affects more than 1.2 billion individuals globally. In addition to anemia, reactive thrombocytosis is also a common clini......

JIF:2.779

TSST-1 protein exerts indirect effect on platelet activation and apoptosis

期刊: PLATELETS, 2022; 33 (7)

Thrombocytopenia or platelet dysfunction is a risk factor for severe infection. Staphylococcus aureus (S. aureus) releases a variety of virulence fact......

JIF:2.779

Clopidogrel versus ticagrelor in East Asian patients aged 75 years or older with acute coronary syndrome: observations from the GF-APT registry

期刊: PLATELETS, 2022; 33 (8)

The benefits of potent antithrombotic therapy usually come at the expense of a higher risk of bleeding. The efficacy and safety of ticagrelor in elder......

JIF:2.779

Deletion of SDF-1 or CXCR4 regulates platelet activation linked to glucose metabolism and mitochondrial respiratory reserve

期刊: PLATELETS, 2022; 33 (4)

Stromal cell-derived factor 1 (SDF-1, also known as CXCL12) and its receptor CXCR4 have shown to play a role in the homing and engraftment of hematopo......

JIF:2.779

Crushed/chewed administration of potent P2Y(12) inhibitors in ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: Systematic review and meta-analysis

期刊: PLATELETS, 2022; 33 (5)

Crushed or chewed potent P2Y(12) inhibitors are commonly used in the hope of bridging the gap of platelet inhibition in patients with ST-segment eleva......

JIF:2.779

Relationship between Hepatitis B virus infection and platelet production and dysfunction

期刊: PLATELETS, 2022; 33 (2)

Hepatitis B virus (HBV) is a kind of hepatotropic DNA virus. The main target organ is liver, except for liver, HBV has been found in a variety of extr......

JIF:2.779

Association between platelet counts and morbidity and mortality after endovascular repair for type B aortic dissection

期刊: PLATELETS, 2022; 33 (1)

This study aimed to assess the association of postoperative platelet counts with early and late outcomes after thoracic endovascular aortic repair (TE......

JIF:2.779

Platelet index on admission as a predictor of bacteremia in acute cholangitis: a 7-year retrospective observational study

期刊: PLATELETS, 2022; 33 (8)

Bacteremia frequently occurs in patients with acute cholangitis, which could increase the risk of mortality. This single-center retrospective observat......

JIF:2.779

Avatrombopag improves thrombocytopenia in MYH9-related disorder following eltrombopag treatment failure

期刊: PLATELETS, 2022; 33 (8)

MYH9-related disorder (MYH9-RD) is autosomal dominant thrombocytopenia caused by mutations in the MYH9 gene, which codes for the non-muscle myosin-IIA......

JIF:2.779

Platelet Parameters and Risk of Hypertension disorders of Pregnancy: a Propensity Score Adjusted Analysis

期刊: PLATELETS, 2022; 33 (4)

While the role of platelets in cardiovascular diseases among the general population has been widely reported, evidence is inconsistent regarding the a......

JIF:2.779

Performance of the REACH, PARIS, BleeMACS, and PRECISE-DAPT scores for predicting 1-year bleeding events in patients undergoing coronary drug-eluting stent implantation

期刊: PLATELETS, 2022; 33 (5)

This study aimed to evaluate the predictive performance of the REACH, PARIS, BleeMACS, and PRECISE-DAPT scores in Chinese patients undergoing coronary......

JIF:2.779

Safety and efficacy of low-dose ticagrelor in Chinese patients with acute coronary syndrome undergoing percutaneous coronary intervention

期刊: PLATELETS, 2022; 33 (2)

It remains unclear whether low-dose ticagrelor offers better safety and similar efficacy for Asian patients with acute coronary syndromes (ACS). We ai......

JIF:2.779

Chronic immune thrombocytopenia in a child with X-linked agammaglobulinemia-an uncommon phenotype

期刊: PLATELETS, 2022; 33 (7)

Autoimmune disorders are common in patients with primary immunodeficiency diseases (PIDs). However, the prevalence of autoimmunity is low in patients ......

JIF:2.779

共89条页码: 1/6页15条/页